In US and Canada Call Toll Free: (877) 597-9236
Everywhere Else Call: (760) 431-6300

Communication Channels for Immunology Researchers

percepta

22nd Feb, 2013

Articles, Blog

0

If you are looking for ways to communicate with researchers that identify themselves as immunology researchers, some of Percepta’s latest data suggests the popularity of various information sources spans a pretty broad spectrum. Search engines still rank high as a place immunologist look for product information. Also popular are peer recommendations, journal citations and company web sites, with more…

read more >

How Many “Omics” Does it Take to Study a Single Cell?

percepta

18th Feb, 2013

Articles, Blog

0

As has been shown again and again, seemingly homogeneous cell populations often consist of more than one cell type, which can confound research results. Single-cell research offers a bottom-up approach to circumventing such unwanted cellular heterogeneity. As a testament to its potential promise, the NIH has committed ~$90 million over 5 years to single cell analysis research. At Percepta,…

read more >

Poll of Fluorescent Imaging Reagent User Budgets Reveals Commercial Users more Optimistic

percepta

12th Feb, 2013

Blog, Polls

0

In February 2013 we polled our panel of fluorescent imaging reagent users regarding their anticipated laboratory budget. Data reveals that commercial users anticipate a slight increase compared to academic users. As shown in the table, 24.1% of commercial users of fluorescent imaging reagents expect their budget to increase over the next 12 months, vs. 17.6% of academic users (a…

read more >

Take Another Look at Cell Therapy

percepta

5th Feb, 2013

Blog, Polls

0

If you thought cell therapy had suffered too many setbacks in recent years and was stuck in neutral – think again. In a recent Percepta poll of 250 randomly selected life science researchers working in biotechnology and pharmaceutical companies more than 20% are involved in projects focused on allogeneic or autologous cell therapy and/or regenerative medicine. Even more surprising…

read more >

Growth of Chinese Cell Culture Market Driven Largely by Fetal Bovine Serum Reported in 2012 Chinese Cell Culture Life Science Dashboard™

percepta

25th Sep, 2012

News

0

Market Report from Percepta Associates Chinese Researchers more willing to switch between cell culture suppliers for improved service and support

Carlsbad, Calif. – September 25, 2012 – Today, Percepta Associates announced the launch of its Series One 2012 Chinese Cell Culture Life Science Dashboard™ market research report, providing rapid access to actionable key market indicators for the Chinese cell culture…

read more >

Life Technologies Solidifies Leadership Position in Mammalian Cell Culture Market Reported in 2012 Cell Culture Life Science Dashboard™ Market Report from Percepta Associates

percepta

5th Sep, 2012

News

0

Sigma, Thermo Fisher, MediaTech and Lonza Jostle for Second Position Revealing a Changing Competitive Landscape Compared to 2010 Cell Culture Life Science DashboardTM Findings

Carlsbad, Calif. – September 5, 2012 – Today, Percepta Associates announces the launch of its Series Four 2012 Cell Culture Life Science DashboardTM market research report, providing rapid access to actionable key market indicators for the…

read more >

Opportunities for Workflow Improvements at Every Stage of Protein Electrophoresis & Western Analysis

percepta

1st Feb, 2012

News

0

Revealed in New Protein Electrophoresis & Western Analysis Life Science DashboardTM from Percepta Associates

Carlsbad, Calif. – February 1, 2012 – Today, Percepta Associates announces the launch of the 2012 Protein Electrophoresis & Western Analysis, Series 1 Life Science DashboardTM market research report. This Dashboard reveals key market indicators, such as market size, market shares, growth rates, customer satisfaction/ propensity…

read more >

Qiagen Sweeps all 13 Market Segments in New Percepta Nucleic Acid Isolation Report

percepta

17th Oct, 2011

News

0

Nucleic Acid Purification Series 3 Life Science DashboardTM from Percepta Associates shows Qiagen market share declines in small scale plasmid isolation offset by gains in total RNA purification segments

Carlsbad, Calif. – October 17, 2011 – Today Percepta Associates announces the launch of the 2011 Nucleic Acid Purification Series 3 Life Science DashboardTM market research report, providing rapid access to…

read more >

Life Technologies Maintains Leadership in Research Market for Amplification Reagents and Instruments

percepta

10th Oct, 2011

News

0

Researchers are looking to lower priced reagent options as budget purse strings tighten

Carlsbad, Calif. – October 10, 2011 – Today Percepta Associates announces the launch of the 2011 Nucleic Acid Amplification Series 3 Life Science DashboardTM market research report, providing rapid access to actionable key market indicators for the nucleic acid amplification market. The 2011 Dashboard draws comparisons to…

read more >

Flow Cytometry Market Leaders Must Look to Reagent Segment for Growth in 2011

percepta

9th Aug, 2011

News

0

Researchers demand wider array of antibody product offerings from preferred suppliers for proteins of interest

Carlsbad, Calif. – August 9, 2011 – Today, Percepta Associates announced the launch of the 2011 Flow Cytometry Series 1 Life Science DashboardTM market research report. This report provides rapid access to actionable key market indicators for both reagents and instruments in the flow cytometry…

read more >

Copyright © 2025 Percepta Associates Inc. All rights reserved. Terms & Conditions.